Celsius Holdings, Inc. Common Stock
CELH
$28.02
-4.76%
Celsius Holdings operates in the energy drink subsegment of the global nonalcoholic beverage market, with 95% of revenue concentrated in North America. It owns three energy drink brands: Celsius, Alani Nu, and Rockstar Energy, positioning itself as a multi-brand growth platform. The company focuses on product innovation and marketing while outsourcing manufacturing and distribution to PepsiCo, which holds an 11% stake. The current investor narrative centers on whether Celsius can sustain its growth trajectory following the Alani Nu acquisition, as recent revenue acceleration and margin expansion have been overshadowed by a sharp stock decline and competitive pressures from larger players like Monster and Costco.…
CELH
Celsius Holdings, Inc. Common Stock
$28.02
Related headlines
Investment Opinion: Should I buy CELH Today?
Rating: Buy. Celsius is a high-growth beverage company that has undergone a transformative acquisition, creating a multi-brand platform with strong distribution via PepsiCo. The analyst consensus is Strong Buy with an average target of $55.48, implying 91.4% upside from the current price of $28.99.
Supporting Evidence: The forward P/E of 14.65x is attractive relative to the trailing P/E of 182.96x and implies significant earnings growth. Revenue grew 137.7% YoY in Q1 2026 to $782.6 million, driven by Alani Nu. Gross margin expanded to 48.3% in Q1 2026, and operating margin reached 17.8%. Free cash flow was positive at $65.8 million in Q1 2026, and the company has $549.2 million in cash with low debt. The PEG ratio is negative due to trailing earnings distortion, but forward estimates suggest a PEG below 1.0 if growth sustains.
Risks & Conditions: The biggest risks are earnings volatility from acquisition integration, intense competition from Monster and Costco, and the stock's sustained downtrend. This Buy rating would be downgraded to Hold if revenue growth decelerates below 20% YoY or if gross margins fall below 45%. It would be upgraded to Strong Buy if the stock breaks above its 50-day moving average and analyst targets are raised. Overall, Celsius appears undervalued relative to its forward earnings potential but overvalued on a trailing basis; the key is execution on growth.
Sign up to view all
CELH 12-Month Price Forecast
Celsius presents a compelling risk/reward at current levels. The forward P/E of 14.65x is deeply discounted relative to the growth trajectory, and analyst consensus supports significant upside. However, the stock is in a downtrend and faces competitive headwinds. The base case of a recovery to the average target of $55.48 is the most probable, driven by successful Alani Nu integration and margin expansion. The bull case requires sustained high growth and margin improvement, while the bear case hinges on competitive pressures. I would upgrade to a more bullish stance if the stock breaks above $35 with strong volume, and downgrade to neutral if revenue growth falls below 20%.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Celsius Holdings, Inc. Common Stock's 12-month outlook, with a consensus price target around $55.48 and implied upside of +98.0% versus the current price.
Average Target
$55.48
0 analysts
Implied Upside
+98.0%
vs. current price
Analyst Count
—
covering this stock
Price Range
$41 - $85
Analyst target range
Celsius is covered by 21 analysts, with a consensus recommendation of 'Buy' and a mean recommendation score of 1.57 (where 1 is Strong Buy and 5 is Sell). The average target price is $55.48, implying a 91.4% upside from the current price of $28.99. The distribution leans heavily bullish, with no sell ratings in the recent institutional ratings data, which includes upgrades from Citigroup, Needham, UBS, and others. The target range spans from a low of $41.00 to a high of $85.00, representing a 42.8% to 193.2% upside. The high target of $85.00 assumes successful integration of Alani Nu, continued market share gains, and margin expansion, while the low target of $41.00 reflects risks from competition and potential growth deceleration. The wide spread (high-to-low difference of $44) indicates high uncertainty about the company's future trajectory. Recent ratings have been uniformly positive, with firms like Morgan Stanley and JP Morgan reiterating Overweight ratings in May and June 2026, suggesting analysts see the current pullback as a buying opportunity. However, the stock's significant decline below the low target suggests that the market is pricing in more pessimistic outcomes than the analyst consensus.
Bulls vs Bears: CELH Investment Factors
Celsius presents a high-risk, high-reward opportunity. The bull case rests on transformative revenue growth from the Alani Nu acquisition, a strong balance sheet, and a deeply discounted forward P/E of 14.7x that implies significant earnings recovery. Analyst consensus is overwhelmingly bullish, with an average target suggesting 91% upside. However, the stock is in a sustained downtrend, down 35% over the past year, and trades near its 52-week low. The trailing P/E of 183x is extreme, and earnings have been volatile due to acquisition-related costs. Intense competition from Monster and Costco, along with North American revenue concentration, add to the risk. The single most important tension is whether the company can deliver the earnings growth implied by the forward P/E—if EPS reaches $2.80, the stock is undervalued; if growth disappoints, the stock could fall further. Currently, the bearish technical momentum and valuation risk are more immediate, but the fundamental setup for a recovery is compelling. The evidence slightly favors the bull case over a 12-month horizon, given the analyst support and low forward multiple.
Bullish
- Revenue Growth Accelerating via Alani Nu: Q1 2026 revenue surged 137.7% YoY to $782.6 million, driven by the Alani Nu acquisition. This transforms Celsius into a multi-brand platform with combined scale, offsetting slowing core brand growth.
- Analyst Consensus Strong Buy with 91% Upside: 21 analysts rate Celsius a Buy with an average target of $55.48, implying 91.4% upside from $28.99. No sell ratings exist, and recent upgrades from Citigroup, Needham, and UBS reinforce bullish sentiment.
- Forward P/E Compressed to 14.7x: The forward P/E of 14.65x is dramatically lower than the trailing P/E of 182.96x, suggesting the market expects a sharp earnings recovery. If EPS estimates of $2.80 materialize, the stock trades at a reasonable multiple for a growth company.
- Solid Balance Sheet with Low Debt: Celsius holds $549.2 million in cash with a debt-to-equity ratio of only 0.23. Free cash flow was $65.8 million in Q1 2026, providing financial flexibility to invest in growth or weather competitive pressures.
Bearish
- Stock in Sustained Downtrend, Down 35% in 1 Year: CELH has declined 34.8% over the past year, trading near its 52-week low of $27.47. The stock is at the bottom of its 52-week range (43.4% of the range), indicating persistent selling pressure and weak relative strength vs. the S&P 500.
- Trailing P/E of 183x Reflects Extreme Valuation Risk: Despite the price decline, the trailing P/E of 182.96x is extremely high. Any earnings miss could trigger multiple compression, and the stock has already shown high volatility with a max drawdown of -57.2%.
- Earnings Volatility from Acquisition Costs: Net income swung from a loss of -$61.0 million in Q3 2025 to a profit of $110.1 million in Q1 2026. Such volatility makes it difficult to value the company and increases risk for investors.
- Intense Competition from Monster and Costco: Celsius faces fierce competition from Monster Beverage and private-label brands like Costco's Kirkland. Recent news highlights that Costco's entry into energy drinks is pressuring Celsius' market share and margins.
CELH Technical Analysis
Celsius is in a sustained downtrend, with the stock price declining 34.8% over the past year and currently trading at 43.4% of its 52-week range (closing at $28.99 vs. the 52-week high of $66.74 and low of $27.47). The price sits near the bottom of its 52-week range, suggesting a potential value opportunity but also reflecting persistent selling pressure and bearish sentiment. The 1-year price change of -34.8% significantly underperforms the S&P 500's +18.4% gain, indicating strong relative weakness. Short-term momentum remains negative, with the 1-month price change of -4.6% and 3-month change of -17.8%, both worse than the S&P 500's +0.3% and +4.7% over the same periods. This divergence—where short-term declines accelerate relative to the longer-term downtrend—signals that selling pressure is intensifying, and the stock has not yet found a stable floor. The RSI is not provided, but the persistent price declines suggest oversold conditions may be developing, though no reversal pattern is evident. The 52-week low of $27.47 serves as critical support; a breakdown below this level could trigger further downside toward the next psychological level of $25. Conversely, the 52-week high of $66.74 represents major resistance, and a breakout above would require a 130% rally from current levels. Beta of 0.925 indicates the stock is slightly less volatile than the market, but given its sharp declines, it has exhibited higher downside correlation during market weakness. The short ratio of 3.96 days suggests moderate bearish positioning, but not extreme.
Beta
0.93
0.93x market volatility
Max Drawdown
-57.2%
Largest decline past year
52-Week Range
$27-$67
Price range past year
Annual Return
-35.7%
Cumulative gain past year
| Period | CELH Return | S&P 500 |
|---|---|---|
| 1m | -9.0% | +0.2% |
| 3m | -15.8% | +5.2% |
| 6m | -49.3% | +8.6% |
| 1y | -35.7% | +19.0% |
| ytd | -41.3% | +9.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CELH Fundamental Analysis
Revenue has shown strong growth, with the most recent quarter (Q1 2026) reporting $782.6 million, a 137.7% year-over-year increase from $329.3 million in Q1 2025. This acceleration is largely driven by the Alani Nu acquisition, which transformed Celsius into a multi-brand platform. However, revenue growth has been lumpy: Q2 2025 revenue was $739.3 million, Q3 2025 was $725.1 million, and Q4 2025 was $721.6 million, indicating sequential stabilization after the acquisition boost. The revenue trajectory is robust but faces sustainability questions as integration benefits normalize. Profitability has improved significantly, with net income of $110.1 million in Q1 2026 versus $44.4 million in Q1 2025, and gross margin expanding to 48.3% from 52.3% in the prior year quarter (though down from 51.5% in Q2 2025). Operating margin of 17.8% in Q1 2026 is healthy, but the company reported a net loss in Q3 2025 (-$61.0 million) due to acquisition-related costs, highlighting earnings volatility. The balance sheet is solid, with $549.2 million in cash and cash equivalents, debt-to-equity of 0.23, and free cash flow of $65.8 million in Q1 2026. However, free cash flow was negative in Q4 2025 (-$130.0 million) due to working capital swings, and the current ratio of 1.68 indicates adequate liquidity. ROE of 3.7% is low, reflecting the dilutive impact of PepsiCo's convertible preferred shares, but the company generates sufficient cash to fund operations without external financing.
Quarterly Revenue
$782615000.0B
2026-03
Revenue YoY Growth
+137.7%
YoY Comparison
Gross Margin
48.3%
Latest Quarter
Free Cash Flow
$292759000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CELH Overvalued?
Since net income is positive ($110.1 million in Q1 2026), the P/E ratio is the primary valuation metric. The trailing P/E of 182.96x is extremely high, reflecting the stock's decline from prior highs and the lumpy earnings history. The forward P/E of 14.65x, based on estimated EPS of $2.80, implies a dramatic compression and suggests the market expects significant earnings growth to justify the current price. The gap between trailing and forward P/E indicates that the market is pricing in a sharp earnings recovery, which is plausible given the Alani Nu acquisition. Compared to the industry average P/E (not provided), Celsius trades at a premium to the broader beverage sector, but the forward P/E of 14.65x is more reasonable for a growth company. The P/S ratio of 4.28x is elevated but has compressed from historical highs, reflecting the revenue growth. Historically, the trailing P/E has ranged from negative (during loss quarters) to over 285x (Q4 2025), so the current 182.96x is near the high end of its historical range, indicating that the market is still pricing in optimistic expectations despite the stock's decline. The forward P/E of 14.65x, however, is near the lower end of historical forward multiples, suggesting that if earnings materialize, the stock could be undervalued. The PEG ratio of -4.01 is negative due to negative earnings growth in the trailing period, but this is distorted by acquisition costs.
PE
183.0x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 27x~153x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
54.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Celsius faces significant earnings volatility, as evidenced by a net loss of -$61.0 million in Q3 2025 versus a profit of $110.1 million in Q1 2026. The trailing P/E of 182.96x leaves no room for error; any earnings miss could trigger severe multiple compression. While the debt-to-equity ratio is low at 0.23, free cash flow was negative -$130.0 million in Q4 2025 due to working capital swings, indicating potential cash flow instability. Revenue concentration in North America (95%) and reliance on the Alani Nu acquisition for growth create single points of failure.
Market & Competitive Risks: The stock has underperformed the S&P 500 by 53% over the past year, with a beta of 0.925 indicating slightly less volatility than the market but high downside correlation during selloffs. Competition from Monster Beverage and Costco's private-label energy drinks is intensifying, as highlighted in recent news. The stock trades at a P/S of 4.28x, which is elevated relative to the beverage sector average, leaving it vulnerable to valuation compression if growth decelerates. The short ratio of 3.96 days suggests moderate bearish positioning, but not extreme.
Worst-Case Scenario: If Celsius fails to sustain revenue growth post-Alani Nu integration and faces margin pressure from competition, earnings could disappoint. The stock could retest its 52-week low of $27.47, and a break below that level could trigger further declines toward $25.00, representing a potential loss of -13.8% from the current price of $28.99. In a severe downturn, the stock could fall to $20.00, a -31% decline, based on historical volatility and the max drawdown of -57.2%.
FAQ
The primary risks are: 1) Earnings volatility – net income swung from -$61M in Q3 2025 to +$110M in Q1 2026, making valuation difficult. 2) Intense competition – Monster and Costco's private-label energy drinks threaten market share and margins. 3) Valuation risk – the trailing P/E of 182.96x leaves no room for error; any earnings miss could trigger a sharp selloff. 4) Technical risk – the stock is in a sustained downtrend, down 35% over the past year, and trading near its 52-week low. The most severe risk is a competitive price war that erodes margins and growth.
The 12-month forecast is mixed but leans bullish. The bull case (30% probability) sees the stock reaching $55-$85, driven by sustained high growth and margin expansion. The base case (45% probability) targets $41-$55, assuming moderate growth and stable margins. The bear case (25% probability) sees the stock falling to $27-$41 if competition intensifies or growth disappoints. The most likely scenario is the base case, with the stock recovering to the analyst average of $55.48, implying 91% upside. Key assumptions include successful Alani Nu integration and gross margins holding above 48%.
Celsius appears undervalued on a forward basis but overvalued on a trailing basis. The forward P/E of 14.65x is below the beverage sector average and implies the market is pricing in a sharp earnings recovery. In contrast, the trailing P/E of 182.96x is extremely high, reflecting past losses and acquisition costs. The P/S ratio of 4.28x is elevated but has compressed from historical levels. Compared to its own history, the forward P/E is near the low end, suggesting the stock is cheap relative to expected earnings. The market is pricing in optimistic growth expectations, but if those materialize, the stock is undervalued.
Celsius offers a high-risk, high-reward opportunity. The stock trades at $28.99, near its 52-week low, with an analyst average target of $55.48 implying 91.4% upside. The forward P/E of 14.65x is attractive if the company delivers estimated EPS of $2.80, but the trailing P/E of 182.96x highlights extreme earnings volatility. The biggest downside risk is competition from Monster and Costco, which could pressure margins. For aggressive growth investors with a long-term horizon, CELH could be a good buy at current levels, but conservative investors should wait for confirmation of sustained growth and margin stability.
Celsius is better suited for long-term investment due to its high volatility and speculative nature. The stock has a beta of 0.925, slightly below the market, but its 1-year decline of 34.8% and max drawdown of -57.2% indicate significant short-term risk. The company is in a growth phase with positive free cash flow and a solid balance sheet, but earnings visibility is low due to acquisition integration. Short-term traders could capitalize on volatility, but the recommended holding period is at least 12-24 months to allow the Alani Nu acquisition to deliver on its potential. The stock does not pay a meaningful dividend (yield 0.35%), so it is not suitable for income investors.